Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$669,950
+$70,649 QoQ
Shares Held
12,313
-11.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#389
of 751 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $10,785,344 across 13 Biotechnology names. EXEL ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
59,032 | $3,219,605 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
66,310 | $2,586,752 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,400 | $892,007 | |
| 4 | INSM |
INSMED Inc
|
8,014 | $854,451 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
12,313 | $669,950 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,120 | $556,337 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
9,442 | $540,271 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,002 | $347,973 |
All Filings in EXEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $669,950 | 12,313 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $599,301 | 13,973 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $785,915 | 17,931 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||